Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Heritage Cannabis Holdings Corp HERTF

Heritage Cannabis Holdings Corp. is a Canada-based cannabis company offering products to both the medical and recreational legal cannabis markets in Canada and the United States. It focuses on extraction and the creation of extract and extract-derivative products and brands for adult use and cannabis-based medical solutions. It has a portfolio of cannabis products under the brands Purefarma, Pura Vida, RAD, Premium 5, Thrifty, Adults Only, feelgood., the CB4 suite of medical products in Canada and ArthroCBD in the United States. In Canada, it operates through its subsidiaries, Heritage Cannabis West Corporation (Heritage West) and Heritage Cannabis East Corporation (Heritage East). Heritage West holds a Health Canada issued cultivation, processing, and medical and adult use sales license, as well as an industrial hemp license, a cannabis oil sales license, and a cannabis research license. In the United States, it operates through, Opticann Inc., an oral and topical cannabinoid company.


PINL:HERTF - Post by User

Comment by BobGreenfieldon Jan 04, 2020 8:40pm
33 Views
Post# 30518994

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Weak Q4 numbers then it gets better.

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Weak Q4 numbers then it gets better.Kingfish ....... JWC's revenue plans and projections necessitated the financing ...... a hard "PILL" to swallow when you deal with the Lind group.

Also ....... Canntab is not shining right now ......... and I assure you I'm staying tuned as there is mucho profit to be made off of emotional investors.

Kingfish wrote: I'm saying it's not likely they had a lot of choices with respect to financing, but who knows. Can't call it a bad move just yet. As for canntab, stay tuned, the best is yet to come ;)


Bullboard Posts